Lonza Group AG (LONN) Earnings Call Transcripts

31 earnings calls from January 2020 to July 22, 2026

SWX CH Health Care Life Sciences Tools and Services

Lonza Group AG's Latest Earnings Call - Q1 FY2026

In the Q1 2026 earnings call, Lonza Group AG reported a strong performance across its CDMO business platforms, confirming its full-year guidance of 11% to 12% sales growth at constant exchange rates and core EBITDA margin expansion above 32%. The company anticipates a year-over-year sales growth headwind of approximately 3% due to foreign exchange rates. Management emphasized that the first half of 2026 is expected to outperform the second half, driven by favorable batch release timing and strong demand across various platforms.

Reported metrics

MetricValueContext
Sales Growth 11% to 12% (inline) Confirmed guidance for 2026 at constant exchange rates.
Core EBITDA Margin Above 32% (positive) Expected expansion for 2026.
Year-over-Year Sales Growth Headwind -3% (negative) Due to foreign exchange rates for full year 2026.
CapEx Proceeds from Divestment CHF 1.7 billion (positive) From the divestment of CHI business.
Net Debt-to-EBITDA Ratio < 2 (positive) Indicates strong balance sheet strength.
Expected Start of Commercial Operations at Visp Mid-2026 (neutral) For the large-scale bioconjugation site.

Guidance from management

Lonza maintained its 2026 sales growth guidance of 11% to 12% at constant exchange rates and core EBITDA margin expansion above 32%. They anticipate a year-over-year sales growth headwind of around 3% due to foreign exchange rates.

What management said

Yes, yes, yes. Sorry, Charles, this was not my intention. But you're right. I think as we said in January, we have now fully integrated Vacaville into our Mammalian network. And so I think contracts for specific site will not be shared unless these contracts represent something very special, which we've done in the past. So large strategic contracts or integrated contracts that we will continue to share with you as l...
— Philippe Deecke, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns about the longer decision-making times from customers amid geopolitical uncertainties and U.S. investments. They are particularly interested in understanding the impact of these factors on future contracting momentum and revenue projections.

Main topics on the call

Read the full Lonza Group AG transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Lonza Group AG

Lonza Group AG (LONN) is a publicly listed company in the Life Sciences Tools and Services industry, within the Health Care sector. It trades on SWX and is based in CH. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 31 calls on record spanning January 21, 2020 to July 22, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 31 Lonza Group AG earnings call transcripts on record, spanning January 21, 2020 to July 22, 2026. Based on this history, Lonza Group AG reports quarterly. The most recent call on file is dated July 22, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LONN
Exchange
SWX
Country
CH
Sector
Health Care
Industry
Life Sciences Tools and Services
Calls on record
31
First call
January 21, 2020
Most recent
July 22, 2026
Reporting cadence
quarterly
Quarter Date
Earnings Calls Jul 22, 2026 Read transcript
Q1 FY2026 May 8, 2026 Read transcript
Special Calls Mar 9, 2026 Read transcript
Earnings Calls Jan 28, 2026 Read transcript
Company Conference Presentations Jan 13, 2026 Read transcript
Q1 FY2025 May 9, 2025 Read transcript
Earnings Calls Jan 29, 2025 Read transcript
Company Conference Presentations Jan 14, 2025 Read transcript
Special Calls Dec 12, 2024 Read transcript
Q3 FY2024 Oct 24, 2024 Read transcript
Earnings Calls Jul 25, 2024 Read transcript
Q1 FY2024 May 14, 2024 Read transcript
Special Calls Mar 20, 2024 Read transcript
Earnings Calls Jan 26, 2024 Read transcript
Company Conference Presentations Jan 10, 2024 Read transcript
Analyst/Investor Day Oct 17, 2023 Read transcript
Earnings Calls Jul 21, 2023 Read transcript
Q1 FY2023 May 10, 2023 Read transcript
Earnings Calls Jan 25, 2023 Read transcript
Company Conference Presentations Jan 11, 2023 Read transcript
Special Calls Dec 5, 2022 Read transcript
Earnings Calls Jul 22, 2022 Read transcript
Q4 FY2021 Jan 26, 2022 Read transcript
Analyst/Investor Day Oct 12, 2021 Read transcript
Earnings Calls Jul 23, 2021 Read transcript
Earnings Calls Jan 27, 2021 Read transcript
Company Conference Presentations Jan 13, 2021 Read transcript
Shareholder/Analyst Calls Oct 15, 2020 Read transcript
Earnings Calls Jul 24, 2020 Read transcript
Q1 FY2020 Apr 17, 2020 Read transcript
Earnings Calls Jan 21, 2020 Read transcript